Impact of Explanation Given to Parents on Rate of Post-partum Influenza Vaccination
NCT ID: NCT03053674
Last Updated: 2017-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
208 participants
INTERVENTIONAL
2017-02-20
2017-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influenza Vaccine Postpartum Questionnaire
NCT00401700
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418
Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
NCT00812110
Safety of H1N1 Influenza Vaccination in Pregnant Women
NCT01842997
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
NCT01494740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Explanation
Explanation to parents on importance of post-partum influenza vaccination on health of their newborn infant with a follow-up questionnaire to determine rate of vaccination
Oral and written explanation
Oral and written explanation on importance of post-partum influenza vaccination for the health of their newborn infant
Follow-up questionnaire
Follow-up questionnaire to determine whether participants have receive post-partum vaccination
No explanation
No explanation will be given to parents but they will be followed-up with a questionnaire to determine rate of vaccination
Follow-up questionnaire
Follow-up questionnaire to determine whether participants have receive post-partum vaccination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral and written explanation
Oral and written explanation on importance of post-partum influenza vaccination for the health of their newborn infant
Follow-up questionnaire
Follow-up questionnaire to determine whether participants have receive post-partum vaccination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amit Hochberg, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe Medical Center
Hadera, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC104-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.